Total Funding
66
76
Total FundingGrant raised
Growth Score
-19 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
81924
Foli Bio is building a non-invasive platform to analyze gut health through stool RNA for precision medicine
About the Company
Foli Bio is a precision medicine company transforming gastrointestinal disease diagnosis and drug development through Foli-seq, a novel non-invasive gut transcriptomics platform. By decoding exfoliated human RNA from stool, Foli-seq delivers deep mechanistic insight into inflammation, barrier dysfunction and treatment response. We are building a
scalable insight engine that not only powers our internal diagnostic programs and partnered biomarker discovery across pharma pipelines but also serves as the foundation for AI-driven prediction, stratification, and patient monitoring. Ultimately, Foli-seq is positioned to evolve into a domain-specific foundation model for gut diseases.
